SCHEMBL3342287

SCHEMBL3342287

Cc1ccc(-c2ncccn2)cc1C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK2 Q9HBH9 4/20 0.47
MKNK1 Q9BUB5 3/20 0.47
SIRT3 Q9NTG7 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NTRK1 P04629 1/20 0.44
IL1B P01584 1/20 0.43
PIK3CB P42338 1/20 0.42
NNMT P40261 1/20 0.41
CHUK O15111 1/20 0.41
SYK P43405 1/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
BTK Q06187 1/20 0.41
PARP1 P09874 2/20 0.40
NPC1 O15118 2/20 0.40
MAPT P10636 2/20 0.40
ENPP3 O14638 1/20 0.40
AHR P35869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342661 0.84 TGFBR1 (0.46) MKNK2MKNK1SIRT3TDP1PIK3CB
SCHEMBL15730172 0.81 MKNK2 (0.64) MKNK2MKNK1SIRT3TDP1IL1B
SCHEMBL1785281 0.80 MKNK1 (0.47) MKNK2MKNK1CHUKSMN1; SMN2ALDH1A1
SCHEMBL3346124 0.79 PIK3CB (0.67) MKNK2MKNK1SIRT3TDP1PIK3CB
SCHEMBL3342702 0.78 CHUK (0.68) MKNK2MKNK1SIRT3TDP1CHUK
SCHEMBL7120106 0.77 IKBKB (0.66) MKNK2MKNK1CHUKIKBKB
SCHEMBL3226601 0.76 MKNK1 (0.78) MKNK2MKNK1SIRT3TDP1BTK
SCHEMBL3346810 0.75 MKNK1 (0.52) MKNK2MKNK1SIRT3TDP1PIK3CB
SCHEMBL10320333 0.75 BRD4 (0.46) MKNK2MKNK1SIRT3TDP1IL1B
SCHEMBL3346928 0.75 SIRT3 (0.53) MKNK2MKNK1SIRT3TDP1PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 MKNK2 2356/4885MKNK1 2405/4885SIRT3 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.